Literature DB >> 33634670

Repurposing of Tamoxifen Against the Oral Bacteria.

Ali Abdul Hussein S Al-Janabi1.   

Abstract

OBJECTIVES: Tamoxifen (TAM), which is used for treating breast cancer, has exhibited another important function as an antimicrobial agent. The objective of this study is to investigate the antibacterial action of TAM against the bacteria present in the human oral cavity.
MATERIALS AND METHODS: The bacteria present in the human oral cavity were isolated from healthy individuals. Different concentrations of TAM were tested against the isolated bacteria. Additionally, bactericidal and bacteriostatic effects of TAM were also determined.
RESULTS: Out of 23 isolated bacteria, a greater number of Gram-positive bacteria were highly susceptible to the low concentrations of TAM than Gram-negative bacteria. Kytococcus sedentarius, which is Gram-positive bacterium, and Pseudomonas stutzeri, which is Gram-negative bacterium, needed a high minimum inhibitory concentration value of TAM (2.5 mg/mL) to be inhibited by TAM's bacteriostatic action. Resistance to TAM was also observed in three strains of Gram-positive and four strains of Gram-negative bacteria.
CONCLUSION: TAM has shown a potential antibacterial effect against the bacteria present in the oral cavity, especially against Gram-positive bacteria. This effect is mostly bacteriostatic. This study also found bacterial resistance toward TAM.

Entities:  

Keywords:  Bacteria; Gram-negative; Gram-positive; oral cavity; tamoxifen

Year:  2021        PMID: 33634670      PMCID: PMC7957305          DOI: 10.4274/tjps.galenos.2019.23500

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  47 in total

1.  The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.

Authors: 
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

2.  Anti-Mycobacterial Activity of Tamoxifen Against Drug-Resistant and Intra-Macrophage Mycobacterium tuberculosis.

Authors:  Woong Sik Jang; Sukyung Kim; Biswajit Podder; Md Anirban Jyoti; Kung-Woo Nam; Byung-Eui Lee; Ho-Yeon Song
Journal:  J Microbiol Biotechnol       Date:  2015-06       Impact factor: 2.351

3.  Catheter-related relapsing peritonitis due to Kocuria varians in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  Georgios Meletis; Vasiliki Gogou; Maria Palamouti; Petros Spiropoulos; Kiriaki Xanthopoulou; Paraskevi Tantou; Artemisia Rizou; Vasileios Thomoglou
Journal:  Nefrologia       Date:  2012-07-17       Impact factor: 2.033

4.  The antibiotic alarm.

Authors: 
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

5.  The growing resistance of Klebsiella pneumoniae; the need to expand our antibiogram: case report and review of the literature.

Authors:  Musa A Garbati; Areedj I Al Godhair
Journal:  Afr J Infect Dis       Date:  2013

6.  Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae.

Authors:  Thais Bergamin Lima; Osmar Nascimento Silva; Keyla Caroline de Almeida; Suzana Meira Ribeiro; Dielle de Oliveira Motta; Simone Maria-Neto; Michelle Brizolla Lara; Carlos Roberto Souza Filho; Alicia Simalie Ombredane; Celio de Faria Junior; Nadia Skorupa Parachin; Beatriz Simas Magalhães; Octávio Luiz Franco
Journal:  J Antibiot (Tokyo)       Date:  2016-07-06       Impact factor: 2.649

7.  Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins.

Authors:  Yolanda Sáenz; Laura Briñas; Elena Domínguez; Joaquim Ruiz; Myriam Zarazaga; Jordi Vila; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Clinical presentations, management outcomes, and diagnostic dilemma in Kocuria endophthalmitis.

Authors:  Vivek Pravin Dave; Joveeta Joseph; Avinash Pathengay; Rajeev R Pappuru
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-11-20

9.  Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat.

Authors:  Medini K Annavajhala; Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  Front Microbiol       Date:  2019-01-31       Impact factor: 5.640

10.  A 5-year surveillance on antimicrobial resistance of Acinetobacter isolates at a level-I trauma centre of India.

Authors:  Minu Kumari; Priyam Batra; Rajesh Malhotra; Purva Mathur
Journal:  J Lab Physicians       Date:  2019 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.